InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by Postma Robert W, Director. Director active across 2 companies, notably Ziopharm Oncology INC. In total, 6 filings have been logged. Total volume traded: €60k. The latest transaction was disclosed on 22 June 2022 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations6 total
040,000 shares0
Common Stock
SEC:0000899243-22-024005:0·
040,000 shares0
Common Stock
SEC:0000899243-22-023987:0·
€29,87320,508 shares@ €1.4567100.0% of flow
Common Stock
SEC:0001209191-21-054825·
Ideal exit: 30 May 2022 (T+270)
€29,87320,508 shares@ €1.456750.0% of flow
Common Stock
SEC:0001209191-21-054825:0·
Ideal exit: 30 May 2022 (T+270)
2,500 shares
Common Stock
SEC:0001209191-21-030742·
02,500 shares0
Common Stock
SEC:0001209191-21-030742:0·
6 of 6 declarations
About Postma Robert W
Robert W. Postma is a Director at ZIOPHARM Oncology Inc and Alaunos Therapeutics, Inc. In this role, he participates in the governance of the companies and in strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to board discussions.
